About the Authors
- Xavier M. Teitsma
-
Contributed equally to this work with: Xavier M. Teitsma, Jenny Devenport, Johannes W. G. Jacobs, Attila Pethö-Schramm, Michelle E. A. Borm, Petra Budde, Johannes W. J. Bijlsma, Floris P. J. G. Lafeber
Roles Conceptualization, Formal analysis, Writing – original draft, Writing – review & editing
* E-mail: xavierteitsma@gmail.com
Affiliations Department of Rheumatology and Clinical Immunology, University Medical Center Utrecht, Utrecht University, Utrecht, Netherlands, Department of Rheumatology & Clinical Immunology, Utrecht University, Utrecht, Netherlands
- Jenny Devenport
-
Contributed equally to this work with: Xavier M. Teitsma, Jenny Devenport, Johannes W. G. Jacobs, Attila Pethö-Schramm, Michelle E. A. Borm, Petra Budde, Johannes W. J. Bijlsma, Floris P. J. G. Lafeber
Roles Conceptualization, Formal analysis, Writing – original draft, Writing – review & editing
Affiliation Pharmaceuticals Division, F. Hoffmann-La Roche, Basel, Switzerland
- Johannes W. G. Jacobs
-
Contributed equally to this work with: Xavier M. Teitsma, Jenny Devenport, Johannes W. G. Jacobs, Attila Pethö-Schramm, Michelle E. A. Borm, Petra Budde, Johannes W. J. Bijlsma, Floris P. J. G. Lafeber
Roles Conceptualization, Formal analysis, Writing – original draft, Writing – review & editing
Affiliations Department of Rheumatology and Clinical Immunology, University Medical Center Utrecht, Utrecht University, Utrecht, Netherlands, Department of Rheumatology & Clinical Immunology, Utrecht University, Utrecht, Netherlands
- Attila Pethö-Schramm
-
Contributed equally to this work with: Xavier M. Teitsma, Jenny Devenport, Johannes W. G. Jacobs, Attila Pethö-Schramm, Michelle E. A. Borm, Petra Budde, Johannes W. J. Bijlsma, Floris P. J. G. Lafeber
Roles Conceptualization, Formal analysis, Writing – original draft, Writing – review & editing
Affiliation Pharmaceuticals Division, F. Hoffmann-La Roche, Basel, Switzerland
- Michelle E. A. Borm
-
Contributed equally to this work with: Xavier M. Teitsma, Jenny Devenport, Johannes W. G. Jacobs, Attila Pethö-Schramm, Michelle E. A. Borm, Petra Budde, Johannes W. J. Bijlsma, Floris P. J. G. Lafeber
Roles Conceptualization, Formal analysis, Writing – original draft, Writing – review & editing
Affiliation Roche Nederland BV, Woerden, Netherlands
- Petra Budde
-
Contributed equally to this work with: Xavier M. Teitsma, Jenny Devenport, Johannes W. G. Jacobs, Attila Pethö-Schramm, Michelle E. A. Borm, Petra Budde, Johannes W. J. Bijlsma, Floris P. J. G. Lafeber
Roles Data curation, Formal analysis, Writing – original draft, Writing – review & editing
Affiliation Department of Medical Research, Oncimmune Germany GmbH, Dortmund, Germany
- Johannes W. J. Bijlsma
-
Contributed equally to this work with: Xavier M. Teitsma, Jenny Devenport, Johannes W. G. Jacobs, Attila Pethö-Schramm, Michelle E. A. Borm, Petra Budde, Johannes W. J. Bijlsma, Floris P. J. G. Lafeber
Roles Formal analysis, Writing – original draft, Writing – review & editing
Affiliations Department of Rheumatology and Clinical Immunology, University Medical Center Utrecht, Utrecht University, Utrecht, Netherlands, Department of Rheumatology & Clinical Immunology, Utrecht University, Utrecht, Netherlands
- Floris P. J. G. Lafeber
-
Contributed equally to this work with: Xavier M. Teitsma, Jenny Devenport, Johannes W. G. Jacobs, Attila Pethö-Schramm, Michelle E. A. Borm, Petra Budde, Johannes W. J. Bijlsma, Floris P. J. G. Lafeber
Roles Conceptualization, Formal analysis, Writing – original draft, Writing – review & editing
Affiliations Department of Rheumatology and Clinical Immunology, University Medical Center Utrecht, Utrecht University, Utrecht, Netherlands, Department of Rheumatology & Clinical Immunology, Utrecht University, Utrecht, Netherlands
Competing Interests
The authors who enrolled patients (JWJB and JWGJ) received reimbursement for the included patients from Roche Nederland BV. JWJB reports grants and consulting fees from Roche, SUN, and Lilly. JD and AP-S hold stock/stock options in and are employees of F Hoffmann-La Roche. MEAB is an employee of Roche Nederland BV. PB is an employee of Oncimmune Germany GmbH and received reimbursement from Oncimmune Germany GmbH for performing autoantibody measurements. FPJGL reports grants from Roche. XMT is an employee of F Hoffmann-La Roche. These competing interests do not alter our adherence to PLOS ONE policies on sharing data and materials.